Home / Market News / $INMD

$INMD news and market catalysts

The 3 most recent market catalysts affecting $INMD, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

3 catalysts 0 high impact 0 bullish 2 bearish Medical Devices
Aug 5, 2026 Corporate Catalyst Bearish Impact 75
InMode Lowers FY2026 Adj EPS Guidance from $1.33-$1.38 to $1.29-$1.34 vs $1.34 Est; Affirms FY2026 Sales Guidance of $365.000M-$375.000M vs $370.301M Est
InMode (INMD) has revised its adjusted EPS guidance for FY2026 downwards from $1.33-$1.38 to $1.29-$1.34, which is now below the analyst consensus estimate of $1.34. This reduction…
Aug 5, 2026 Corporate Catalyst Bearish Impact 75
InMode Q2 Adj. EPS $0.35 Beats $0.33 Estimate, Sales $95.589M Beat $93.032M Estimate
InMode's Q2 earnings report shows a mixed picture. While the company managed to beat analyst consensus estimates for both EPS and sales, the year-over-year comparison reveals a sig…
Jul 13, 2026 Corporate Catalyst Neutral Impact 65
InMode Reports Preliminary Q2 Sales Of $95.2M-$95.4M; Reaffirms FY2026 Sales Guidance Of $365M-$375M
InMode released preliminary Q2 2026 sales figures, which are largely in line with expectations, and reaffirmed its full-year 2026 revenue guidance. This suggests operational stabil…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.